Pirfenidone for idiopathic pulmonary fibrosis

被引：63
|
作者：
Bouros, Demosthenes [1 ]
机构：
[1] Democritus Univ Thrace, Sch Med, Dept Pneumonol, Alexandroupolis 68100, Greece
来源：
LANCET | 2011年 / 377卷 / 9779期
关键词：
D O I：
10.1016/S0140-6736(11)60546-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1727 / 1729
页数：3
相关论文
共 50 条
  • [31] Pirfenidone: an orphan drug for treating idiopathic pulmonary fibrosis
    Miura, Yukiko
    Azuma, Arata
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (05): : 587 - 597
  • [32] PREDICTIVE FACTORS FOR THE EFFECT OF PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS
    Ichimura, Y.
    Tsushima, K.
    Matsumura, T.
    Yokota, A.
    Terada, J.
    Iesato, K.
    Sakao, S.
    Tada, Y.
    Tanabe, N.
    Tatsumi, K.
    RESPIROLOGY, 2014, 19 : 30 - 30
  • [33] Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
    van Manen, Mirjam J. G.
    Birring, Surinder S.
    Vancheri, Carlo
    Vindigni, Virginia
    Renzoni, Elisabetta
    Russell, Anne-Marie
    Wapenaar, Monique
    Cottin, Vincent
    Wijsenbeek, Marlies S.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (04)
  • [34] Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
    Glassberg, Marilyn K.
    Wijsenbeek, Marlies S.
    Gilberg, Frank
    Petzinger, Ute
    Kirchgaessler, Klaus-Uwe
    Albera, Carlo
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (03)
  • [35] Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis
    Arai, Toru
    Inoue, Yoshikazu
    Sasaki, Yumiko
    Tachibana, Kazunobu
    Nakao, Keiko
    Sugimoto, Chikatoshi
    Okuma, Tomohisa
    Akira, Masanori
    Kitaichi, Masanori
    Hayashi, Seiji
    RESPIRATORY INVESTIGATION, 2014, 52 (02) : 136 - 143
  • [36] CLINICAL EFFICACY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Yamauchi, H.
    Bando, M.
    Sata, M.
    Nakasone, E.
    Mizushina, Y.
    Suzuki, E.
    Mato, N.
    Nakaya, T.
    Yamasawa, H.
    Sugiyama, Y.
    RESPIROLOGY, 2011, 16 : 318 - 319
  • [37] Pirfenidone: a guide to its use in idiopathic pulmonary fibrosis
    Gillian M. Keating
    Katherine A. Lyseng-Williamson
    Natalie J. Carter
    Drugs & Therapy Perspectives, 2012, 28 (7) : 10 - 13
  • [38] Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis
    Bonella, Francesco
    Wessendorf, Thomas
    Costabel, Ulrich
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [39] Marked Improvement with Pirfenidone in a Patient with Idiopathic Pulmonary Fibrosis
    Miyamoto, Atsushi
    Morokawa, Nasa
    Takahashi, Yui
    Ogawa, Kazumasa
    Takeyasu, Makiko
    Murase, Kyoko
    Hanada, Shigeo
    Uruga, Hironori
    Mochizuki, Sayaka
    Takaya, Hisashi
    Kurosaki, Atsuko
    Kishi, Kazuma
    INTERNAL MEDICINE, 2016, 55 (06) : 657 - 661
  • [40] THE PREDICTIVE FACTORS FOR THE EFFECT OF PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS
    Ichimuray
    Tsushima, K.
    Matsumura, T.
    Yokota, A.
    Terada, J.
    Iesato, K.
    Sakao, S.
    Tada, Y.
    Tanabe, N.
    Tatsumi, K.
    RESPIROLOGY, 2014, 19 : 148 - 148
12345